Target intelligence / Profile preview

LIMS1 antisense RNA 1 (LIMS1-AS1)

Target
LIMS1-AS1
Molecular classification
long non-coding RNA, antisense RNA, natural antisense transcript (NAT)
01

Overview

LIMS1 antisense RNA 1 (LIMS1-AS1) is a presumed antisense long non-coding RNA transcribed from the LIMS1 gene locus. Antisense lncRNAs typically regulate gene expression by interacting with their sense counterparts or with chromatin, influencing transcription, mRNA stability, or translation. While many antisense lncRNAs are implicated in cancer and other diseases, there is currently no published, peer-reviewed data specifically describing the function, disease relevance, or druggability of LIMS1-AS1. The related protein-coding gene, LIMS1, participates in integrin signaling, cell adhesion, and cytoskeleton organization, and is known to be involved in cancer cell survival and adaptation to hypoxic conditions, but no direct regulatory role of LIMS1-AS1 in these processes is established in the literature as of 2024.

Other names
LIMS1-AS1
02

Mechanism of action

Theoretical mechanisms (by analogy with other antisense lncRNAs): Gene silencing through transcriptional interference; Regulation of mRNA stability (by RNA-RNA duplex formation); Acting as ceRNA (microRNA "sponging")

03

Biological functions

Regulation of gene expression (transcriptional and post-transcriptional)Chromatin remodelingEpigenetic regulationRNA interference/ceRNA activity (competitive endogenous RNA)
04

Disease associations

Cancer (oncogenesis, tumor progression, drug resistance)Cell proliferationApoptosisEpigenetic diseases
05

Safety considerations

off-target effectsimmune stimulation

Beyond the preview

Go deeper on LIMS1 antisense RNA 1 (LIMS1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIMS1 antisense RNA 1 (LIMS1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call